• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RNV

RENERVE LIMITED

12.5% ! 10.5¢
Market Cap $11.57M  !

ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve... ReNerve Limited is an Australia-based biotechnology company engaged in advanced nerve repair and regeneration solutions. The Company is focused on commercializing medical devices and tissue engineering products that address significant unmet needs in peripheral nerve damage patients. It is also developing tissue-based products for peripheral nerve repair and replacement and other related soft tissue surgical procedures. It is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, tissue compatible protective wrap used to protect repaired injured nerves. It consists of a pliable scaffolding material that can be wrapped around the nerve, protecting surgical repairs and conforming to the nerve’s final shape, allowing regeneration to occur. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RNV 14/07/25 0 186
14/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  186 
RNV 14/07/25 0 134
14/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  134 
RNV 11/07/25 0 235
TRENDING NEWS

Exclusive Pre-IPO & Investment Opportunities in Australia & North America

NEWS
29 Jul 2025
11/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  235 
RNV 10/07/25 4 1.5K
10/07/25 Last post  seaforth1 Comments Created with Sketch.  4  Views Created with Sketch.  1.5K 
RNV 02/06/25 1 726
02/06/25 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  726 
RNV
ReNerve snaffles approval in Bahrain, looks to expand throughout the ME
28/05/25 0 315
28/05/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  315 
RNV 28/05/25 1 574
28/05/25 Last post  seaforth1 Comments Created with Sketch.  1  Views Created with Sketch.  574 
RNV 09/05/25 2 1.1K
09/05/25 Last post  RandAlThor1 Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 

See All Discussions arrow Created with Sketch.

Timeline

Cleansing Notice
14 Jul 08:50
 
Application for quotation of securities - RNV
14 Jul 08:48
 
Proposed issue of securities - RNV
11 Jul 08:53
 
Investor presentation - the Berkeley Biologics Partnership
03 Jun 10:41
 
Expands Product Portfolio with Berkley partnership / Webinar
02 Jun 09:37
 
ReNerve receives market approval in Bahrain
28 May 09:46
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
10.5¢
Change
-0.015(12.5%)
Mkt cap ! $11.57M
Open High Low Value Volume
12.0¢ 12.0¢ 10.0¢ $7.566K 67.63K

Buyers (Bids)

No. Vol. Price($)
4 163629 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 1814 1
View Market Depth
Last trade - 15.24pm 29/07/2025 (20 minute delay) ?
RNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.